SEC Form 4 · accession 0000899243-17-017762
Eledon Pharmaceuticals, Inc. · ELDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cheryl Cohen
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404281
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.85 | Jun 30, 2017 | A | 18,000 | A | — | Jun 30, 2027 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock. The shares will vest ratably each quarter over three years beginning on June 30, 2017.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney.